Buffington Mohr Mc Neal Eli Lilly & CO Transaction History

Buffington Mohr Mc Neal

$551 Million
Q1 2024

A detailed history of Buffington Mohr Mc Neal transactions in Eli Lilly & CO stock. As of the latest transaction made, Buffington Mohr Mc Neal holds 2,965 shares of LLY stock, worth $2.76 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

2,965

Previous 3,003 1.27%

Holding current value

$2.76 Million

Previous $1.75 Million 31.77%

% of portfolio

0.42%

Previous 0.35%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$592.2 - $792.28 $22,503 - $30,106	-38 Reduced 1.27%	2,965 $2.31 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $33,086 - $39,005	63 Added 2.14%	3,003 $1.75 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $271,687 - $374,562	-625 Reduced 17.53%	2,940 $1.58 Million
Q2 2023 Jul 25, 2023	SELL	$350.74 - $468.98 $271,823 - $363,459	-775 Reduced 17.86%	3,565 $1.67 Million
Q1 2023 Apr 26, 2023	BUY	$310.63 - $364.82 $34,169 - $40,130	110 Added 2.6%	4,340 $1.49 Million

Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $64,310 - $74,934	200 Added 4.96%	4,230 $0
Q3 2022 Oct 11, 2022	BUY	$296.48 - $337.87 $66,708 - $76,020	225 Added 5.91%	4,030 $1.3 Million
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $68,288 - $80,181	-245 Reduced 6.05%	3,805 $1.23 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $133,773 - $166,246	-570 Reduced 12.34%	4,050 $1.16 Million
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $144,040 - $177,261	-650 Reduced 12.33%	4,620 $1.07 Million
Q2 2021 Jul 28, 2021	SELL	$180.55 - $233.54 $54,165 - $70,062	-300 Reduced 5.39%	5,270 $1.21 Million
Q1 2021 Apr 14, 2021	SELL	$164.32 - $212.72 $94,484 - $122,314	-575 Reduced 9.36%	5,570 $1.04 Million
Q4 2020 Jan 20, 2021	BUY	$130.46 - $172.63 $165,031 - $218,376	1,265 Added 25.92%	6,145 $1.04 Million
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $54,832 - $63,423	375 Added 8.32%	4,880 $722,000
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $68,210 - $82,090	500 Added 12.48%	4,505 $740,000
Q1 2020 Apr 08, 2020	BUY	$119.05 - $147.35 $192,861 - $238,707	1,620 Added 67.92%	4,005 $556,000
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $480,828 - $561,248	-4,340 Reduced 64.54%	2,385 $264,000
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $17,253 - $20,308	-155 Reduced 2.25%	6,725 $873,000
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $87,897 - $98,471	830 Added 13.72%	6,880 $796,000
Q3 2018 Oct 25, 2018	BUY	$85.86 - $107.31 $9,444 - $11,804	110 Added 1.85%	6,050 $649,000
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $8,327 - $9,556	-110 Reduced 1.82%	5,940 $507,000
Q1 2018 Apr 26, 2018	BUY	$74.21 - $87.6 $98,328 - $116,069	1,325 Added 28.04%	6,050 $468,000
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $364,155 - $404,176	4,725	4,725 $396,000

Others Institutions Holding LLY

# of Institutions

3,728

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $886B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buffington Mohr Mc Neal, based on Form 13F filings with the SEC.

News

Stay updated on Buffington Mohr Mc Neal with notifications on news.

Account

Buffington Mohr Mc Neal Eli Lilly & CO Transaction History